Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly for targeting protein kinases involved in inflammatory diseases and cancer. Its structure supports binding to ATP sites in kinases, making it valuable in developing drugs that modulate cellular signaling pathways. Also explored for use in central nervous system agents due to its ability to cross the blood-brain barrier. Commonly modified to enhance selectivity and pharmacokinetic properties in drug candidates.